Salivary Cortisol and Cognitive Decline and Alzheimer Disease in Older Adults - Summary - MDSpire

Salivary Cortisol and Cognitive Decline and Alzheimer Disease in Older Adults

  • By

  • Ted K. S. Ng

  • Todd Beck

  • Yashwanth Sudhini

  • Robert S. Wilson

  • Denis A. Evans

  • Kumar B. Rajan

  • July 15, 2026

Share

Objective:

To comprehensively characterize diurnal salivary cortisol in a large, racially diverse cohort of older adults and examine its associations with cognitive decline and incident Alzheimer’s Disease (AD).

Approach:
  • Study Design: Cohort study conducted as part of the Chicago Health and Aging Project (CHAP) involving nearly 4000 older adults.
  • Data Collection: Saliva samples were collected at three times daily (morning, afternoon, evening) to assess diurnal cortisol patterns.
  • Cohort Characteristics: Participants included a stratified random sample of Black and White older adults from the South Side of Chicago.
  • Cortisol Measurement: Five indices of diurnal HPA axis activities were derived to evaluate their associations with cognition and incident AD.
Key Findings:
  • Salivary cortisol is a noninvasive and specific marker of biologically active cortisol exposure.
  • Higher peripheral cortisol levels have been linked to hippocampal atrophy and increased AD risk.
  • Existing studies show mixed results on the relationship between cortisol levels and cognitive outcomes.
Interpretation:

Limitations:
  • Previous studies often utilized cross-sectional designs and small, homogeneous samples.
  • Limited examination of nonlinear associations and longitudinal cognitive change.
Conclusion:

The study aims to fill gaps in understanding the relationship between diurnal cortisol patterns and cognitive decline in a diverse older adult population.

Sources:

Original Source(s)

Related Content